Another study revealed that higher levels of other sEH metabolites, such as 14,15 DiHETE and 19,20 DiHDPA, were detected in the plasma of human females with Alzheimer’s disease and males with either Alzheimer’s disease or mild cognitive impairment, compared to cognitively normal individuals. Here, EPHX2 is linked to Cognitive impairment.